Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

1Life Healthcare : How Can I Tell if I Have Sleep Apnea?

09/13/2021 | 12:32am EDT

If you think you may have sleep apnea, think about whether you experience signs besides snoring. Do you wake up exhausted every day, or experience morning headaches? Do you find it difficult to focus on work or school no matter how much sleep you get? If so, you may want to talk to your primary care provider about sleep apnea.

Along with reviewing your symptoms and medical history, your provider may use sleep apnea screening questionnaires, such as the STOP-BANG or the Epworth Sleepiness Scale, to assess your risk of sleep apnea. If your primary care provider thinks you are at high risk for sleep apnea, they may order a sleep test called a polysomnography, that can often be done from the comfort of your own home. The home sleep test monitors your breathing, oxygen level, and heart rate. In some cases, a sleep test needs to be performed in a lab to capture additional information such as brain waves. While this is helpful for complicated presentations of sleep apnea and other sleep disorders, most people will benefit just from a home sleep study.

If a sleep apnea diagnosis is confirmed, your healthcare provider may offer differing treatment depending on the severity of your symptoms. Common treatments for sleep apnea include any combination of the following:

  • Healthy lifestyle changes, like weight loss or quitting drinking or smoking
  • Treating underlying problems, such as heart failure or diabetes
  • A breathing device called a continuous positive airway pressure (CPAP) machine that keeps the airway open during sleep
  • Oral appliances that keep the throat open at night

In severe cases where other treatments aren't working, a doctor may recommend surgery to correct the underlying problem, such as removing enlarged tonsils or adenoids or shrinking tissue in the back of the mouth.

Sleep apnea is difficult enough to deal with on its own, but when left untreated, can lead to more serious health problems, like high blood pressure, heart problems, or even a stroke. So whether a partner's tired of your snoring or you're experiencing constant fatigue during the day, make sure to talk to a doctor if you think you may have sleep apnea.


1Life Healthcare Inc. published this content on 12 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2021 04:31:05 UTC.

© Publicnow 2021
All news about 1LIFE HEALTHCARE, INC.
09:01a1LIFE HEALTHCARE : Differentiated Approach to Chronic Care Management, “Impact by On..
10/141LIFE HEALTHCARE : One Medical) Announces Date of its Third Quarter 2021 Results Conferenc..
10/08NUTRITION 101 : How to Read and Use Food Labels
10/061LIFE HEALTHCARE : 5 Penis Issues You Shouldn't Ignore
10/021LIFE HEALTHCARE : The Importance of Data Integration in Primary Care
09/281LIFE HEALTHCARE : Do I Need Another COVID-19 Vaccine? What To Know About Additional Doses
09/271LIFE HEALTHCARE : SVB Leerink Starts 1Life Healthcare at Market Perform with $22 Price Ta..
09/211LIFE HEALTHCARE : 5 Supplements You Should Know About
09/181LIFE HEALTHCARE : 7 Hygiene Myths You Should Stop Believing
09/16THE SANDWICH GENERATION : Managing Stress While Caring For Others
More news
Analyst Recommendations on 1LIFE HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 595 M - -
Net income 2021 -217 M - -
Net cash 2021 165 M - -
P/E ratio 2021 -16,0x
Yield 2021 -
Capitalization 4 153 M 4 153 M -
EV / Sales 2021 6,70x
EV / Sales 2022 3,79x
Nbr of Employees 1 957
Free-Float 89,1%
Duration : Period :
1Life Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 1LIFE HEALTHCARE, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 15
Last Close Price 21,42 $
Average target price 35,69 $
Spread / Average Target 66,6%
EPS Revisions
Managers and Directors
Amir Dan Rubin Chairman, President & Chief Executive Officer
Bjorn B. Thaler Chief Financial Officer
Andrew S. Diamond Chief Medical Officer
Stuart Parmenter Chief Technology Officer
Doug Gunderson Senior Vice President-Operations
Sector and Competitors